Regulated apoptosis is part of the development of the nematode Caenorhabditis elegans. In a recent paper in Nature, Yan et al. (2005) describe the in vitro reconstitution of the core components of the worm apoptotic pathway. Based on a structural analysis of the complex between the death activator CED-4 and the antiapoptotic protein CED-9, the authors explain the regulation of activity of CED-4. Intriguingly, CED-4 comprises a AAA+ type ATPase domain yet does not seem to need ATP hydrolysis for activity.
All cells destined to die during the development of a mature worm use a common cell-death pathway (Horvitz, 2003 ). This pathway, initially characterized genetically, requires the sequential participation of the proteins EGL-1, CED-4, and CED-3. These "killer proteins" are under negative regulation by the "protector protein" CED-9. However, biochemical analysis has only given limited snapshots of the molecular basis of this pathway. In a recent paper in Nature, Yan and colleagues (2005) reconstituted the nematode apoptotic pathway from its basic components and provided an atomic level structure of a complex of CED-4 and CED-9. This complex is a key point of regulation in the apoptotic signaling cascade. The picture that now emerges bears a significant resemblance to the core death pathway in humans (Boatright and Salvesen, 2003) but also delivers some surprises.
The objective of the apoptotic pathway in all multicellular animals is to activate a protease. In nematodes, this protease is CED-3 and in humans it is the distant homolog caspase-9. In both species, the protein that activates CED-3-CED-4 in nematodes and Apaf-1 in humans-is present in a latent conformation awaiting activation signals. CED-4 uses a distinct protein, the protector CED-9, to ensure latency, whereas the presumably more evolved Apaf-1 contains its own inhibitory domain. By solving the structure of the CED-9/ CED-4 complex at 2.7 Å resolution, Yan and coworkers (2005) elucidate the mechanism of latency of the nematode CED-4 protease. In this complex, CED-4 is an asymmetric dimer, with one subunit in contact with the protector, CED-9. In the absence of CED-9, CED-4 forms a homotetramer, as judged by gel filtration and electron microscopy. In short, CED-9 occupies the potential interaction sites for the dimer to tetramer transition of CED-4. Formation of a tetramer activates CED-4, which drives the activation of the protease CED-3. In this scenario, the job of the upstream "killer" protein EGL-1 is to bind to and displace the protector, CED-9, thereby allowing the activator, CED-4, to form tetramers spontaneously (see Figure 1) . This is consistent with the comparison of the structure of CED-4/CED-9 with the previously reported structure of CED-9/EGL-1 (Yan et al., 2004).
By using all purified components, the authors reconstituted the essential aspects of this process: the activation of CED-3 by CED-4 and the inhibition of this activation by the CED-9. Furthermore, they showed that addition of EGL-1 to CED-4, inhibited by being in a complex with CED-9, caused an activation of CED-3 by CED-4. They proceeded to confirm some of the structural predictions by constructing mutants of the individual components and testing these mutants in vitro and in vivo.
At first glance, the mechanism of activation of CED-4 in the nematode appears similar to that of Apaf-1 in humans. The activator Apaf-1 is also driven into an oligomer that activates caspase-9, although in humans, the "apoptosome" forms heptamers, unlike the nematode CED-4 which forms tetramers (Acehan et al., 2002). The differences come to light when one looks at the signals required to turn on the activator. In nematodes, EGL-1 displaces CED-9 from CED-4, but in humans the Apaf-1 autoinhibitory domain is displaced by cytochrome C (Li et al., 1997). What is particularly unusual about this difference is that the EGL-1 and the CED-9 counterparts in humans (the Bid family and the Bcl-2 family, respectively) act far upstream of Apaf-1, apparently regulating the release of pro-apoptotic proteins from mitochondria, although using a very similar binding geometry. This radical divergence of function of Bcl-2 family members between nematodes and humans remains a central enigma in understanding apoptosis.
The apoptotic activation complex seems to fulfill the criteria for a cellular machine. It contains several distinct components, it is likely to require energy, and it delivers a predictable outcome (Alberts, 1998). If one accepts the concept of conservation of mechanism in biology, then similar cellular machines that perform analogous functions should use comparable mechanisms. Here again, there seems to be differences between the human and nematode apoptosomes. 
